t:slim X2 Insulin Pump with Basal-IQ Technology

t:slim X2™ Insulin Pump

NEW! Predicts and helps prevent lows with Basal-IQ™ Technology

Watch Video

The Basal-IQ™ Technology Upgrade Program is now available for non-Tandem pump users.

Learn more >

 

Less time low

31%

relative reduction overall in sensor time below 70 mg/dL when clinical study participants used Basal-IQ Technology1

 

Simple to use

91%

of clinical study participants said the Basal-IQ feature on the t:slim X2 Insulin Pump was easy to use.1

 

Fingersticks*

Tandem_720x230_Stats_Zero_Fingersticks

required for mealtime dosing or calibration when using Dexcom G6® Continuous Glucose Monitoring (CGM).2

 

*If glucose alerts and CGM readings do not match symptoms or expectations,
use a blood glucose meter to make diabetes treatment decisions.
 

 

 

tandem_web_icon_video

The t:slim X2 Insulin Pump with Basal-IQ Technology isn’t like other insulin pumps. See why.

Watch Video >

 

 

 

How does Basal-IQ Technology work?

The Basal-IQ feature helps reduce the frequency and duration of low-glucose events by predicting glucose levels 30 minutes ahead and suspending insulin if they are expected to drop below 80 mg/dL.

Basal-IQ_Illustration_1140x600

 

 
 

tandem_web_icon_notes

Responsible Use of Basal-IQ Technology

Systems like the t:slim X2 Insulin Pump with Basal-IQ Technology are not substitutes for active diabetes management, as there are common scenarios in which automated systems cannot prevent hypoglycemia. The Basal-IQ feature relies on continuous CGM readings and will not be able to predict glucose levels and suspend insulin delivery if your CGM is not working properly or is unable to communicate with your pump. Be sure to always use your pump, cartridges, CGM, and infusion sets as instructed and check them regularly to make sure they are working properly. Always pay attention to your symptoms, actively monitor your glucose levels, and treat according to your healthcare provider’s recommendations.

 

 

Technology you expect in a modern device.

 

tandem_web_icon_touchscreen_white

Large color touchscreen

Easy to read, simple to use interface

 

tandem_web_icon_bluetooth_white

Bluetooth® wireless technology

Modern connectivity for a modern world

 

tandem_web_icon_smallest_white

Smallest Available Pump

Up to 38% smaller than other insulin pumps3

 

tandem_web_icon_watertight_white

Watertight construction

Tested to 3 feet for 30 minutes (IPX7)

 

tandem_web_icon_rechargeable_white

Rechargeable battery

Convenient charging via micro-USB port

 

tandem_web_icon_updatable_white

Updatable software4

Update features using a personal computer

 

2300x1440_tslimX2_CGM_System_wShare

Integrated with the new Dexcom G6 CGM System

Known for exceptional accuracy and comfort, Dexcom is the #1-rated CGM brand.5  Benefits of the Dexcom G6 CGM System include:

  • Zero fingersticks*
  • 10-day sensor wear
  • Simple auto-applicator
  • Acetaminophen blocking6
  • View data on your smart device7,8
  • Share your data with up to 5 followers9

 

Don’t want to use CGM? No problem!

When CGM and the Basal-IQ feature are turned off, the t:slim X2 Pump removes the CGM chart and puts the Bolus and Options buttons in the center of the screen for easy access.

 

2300x1440_Simple_Reporting

Reporting made simple

With just a few taps, you can view your insulin delivery and glucose history right on the t:slim X2 Pump's bright color screen. You can also quickly upload your insulin delivery and CGM data from your pump using the t:connect® Diabetes Management Application on either a Mac® or a PC, and generate reports for more in-depth analysis with your healthcare provider.

2300x1440_tsimulator_App

So what's next?

Whether you're ready for a new pump, or you just want to try the simple touchscreen interface of the t:slim X2 Insulin Pump on your mobile device, everything you need is right here:

 

#1 Customer Support

At Tandem, we put as much effort into standing behind our products as we do into designing them. Our #1-rated10 California-based Customer Support Team is available 24 hours a day, 365 days a year.

Contact Support at (877) 801-6901

 

Support resources

  1. Forlenza GP, Li Z, Buckingham BA, Pinsker JE, et al. Predictive low glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: Results of the PROLOG trial [published online August 8, 2018]. Diabetes Care. doi:10.2337/dc18-0771.
  2. Dexcom G6 CGM sold separately
  3. 38% smaller than MiniMed 630G and 670G and at least 28% smaller than MiniMed 530G, Animas Vibe and Omnipod System. Data on file, Tandem Diabetes Care
  4. Additional feature updates are not currently available for the t:slim X2 Pump with Basal-IQ technology and are subject to future FDA approvals. A prescription and additional training may be required to access certain future software updates. Charges may apply.
  5. dQ&A USA Diabetes Connections Surveys, 2009-2018.
  6. G6 readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000mg every 6 hours. Taking a higher dose may affect the G6 readings.
  7. For a list of compatible devices, visit www.dexcom.com/compatibility.
  8. The Dexcom G6 CGM transmitter can only be paired with one medical device (either a Dexcom receiver or t:slim X2 Pump) and one consumer device (phone or tablet) at the same time.
  9. Separate Follow App required.
  10. dQ&A USA Diabetes Connections Surveys, 2013-2018

Indications for Use:
RX ONLY. The t:slim X2 Insulin Pump with Basal-IQ Technology (the System) consists of the t:slim X2 Insulin Pump, which contains Basal-IQ Technology, and a compatible CGM. CGM sold separately. The t:slim X2 Insulin Pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The t:slim X2 Insulin Pump can be used solely for continuous insulin delivery and as part of the System. When the System is used with a compatible iCGM, the Basal-IQ Technology can be used to suspend insulin delivery based on CGM sensor readings. Interpretation of the System results should be based on the trends and patterns seen with several sequential readings over time. CGM also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. Compatible iCGM systems are intended for single patient use and require a prescription. The System is indicated for use in individuals 6 years of age and greater. The System is intended for single patient use and requires a prescription. The System is indicated for use with NovoLog or Humalog U-100 insulin. The System is not approved for use in pregnant women, persons on dialysis, or critically ill patients.  

Important Safety Information >